GTLL Pivots to Health Tech, Dumps EV Charging & GLP-1 Ventures

Ticker: GTLL · Form: 10-K · Filed: Dec 30, 2025 · CIK: 932021

Sentiment: bearish

Topics: Health Technology, Pharmaceutical Supply Chain, Strategic Consulting, Corporate Restructuring, Penny Stock, OTC Markets, Acquisition Termination

TL;DR

**GTLL is making a high-stakes bet on health tech, ditching its failed EV and GLP-1 plays, but the path to profitability remains highly uncertain given its history and nascent operations.**

AI Summary

GLOBAL TECHNOLOGIES LTD (GTLL) reported a strategic pivot during the fiscal year ended June 30, 2025, focusing on health technology and advisory services while divesting from other ventures. The company launched Primecare Supply, LLC in May 2025, a B2B procurement platform for 503B pharmaceuticals, which has already established relationships with multiple manufacturers, resellers, and hundreds of medical clinics, generating revenue on a per-transaction basis. GTLL also formed GTLL Advisory Group, LLC in May 2025, expected to commence revenue-generating operations in fiscal year 2026, offering consulting services to small and mid-sized enterprises in health and wellness. Concurrently, GTLL ceased operations for 10 Fold Services, LLC in June 2025 due to changes in FDA regulations regarding GLP-1 products, transferring its intellectual property to Primecare Supply. Furthermore, GTLL terminated its acquisition of GOe3, LLC, an EV charging station developer, as of June 30, 2025, writing off its investment and associated goodwill, citing GOe3's failure to meet operational and financial milestones. The company reported $0 in research and development costs for both fiscal years 2025 and 2024. As of December 29, 2025, there were 14,688,440,097 shares of Class A common stock outstanding, with a non-affiliate market value of approximately $2,937,688 on December 31, 2024.

Why It Matters

GTLL's strategic shift towards health technology and advisory services, marked by the launch of Primecare Supply and GTLL Advisory, signals a focused effort to capitalize on the expanding health and wellness market. This pivot, coupled with the termination of the GOe3 EV charging acquisition and the cessation of 10 Fold Services' GLP-1 operations, indicates management's decisive action to streamline its portfolio and reallocate resources. For investors, this means a clearer, albeit nascent, business model, but also highlights the inherent risks of a company still finding its footing in competitive sectors. Employees and customers of Primecare Supply could benefit from a more concentrated corporate strategy, while the broader market will watch to see if GTLL can successfully execute its new vision against established competitors in pharmaceutical distribution and consulting.

Risk Assessment

Risk Level: high — The risk level is high due to GTLL's history of losses, the termination of significant business ventures like GOe3 and 10 Fold Services, and the nascent stage of its new core operations. The company explicitly states 'the uncertainty of profitability based upon our history of losses' and the 'risk that we will be unable to secure additional financing in the near future' as key concerns, indicating significant financial instability and reliance on future capital.

Analyst Insight

Investors should approach GTLL with extreme caution, recognizing the company is in a highly speculative phase. Monitor the progress of Primecare Supply, LLC and GTLL Advisory Group, LLC closely for concrete revenue growth and profitability, as the company's future hinges entirely on these new, unproven ventures.

Financial Highlights

debt To Equity
Not Disclosed
revenue
Not Disclosed
operating Margin
Not Disclosed
total Assets
Not Disclosed
total Debt
Not Disclosed
net Income
Not Disclosed
eps
Not Disclosed
gross Margin
Not Disclosed
cash Position
Not Disclosed
revenue Growth
N/A

Revenue Breakdown

SegmentRevenueGrowth
Primecare Supply, LLCNot DisclosedN/A
GTLL Advisory Group, LLC$0N/A
10 Fold Services, LLC$0N/A

Key Numbers

Key Players & Entities

FAQ

What are GLOBAL TECHNOLOGIES LTD's primary business operations as of fiscal year 2025?

As of fiscal year 2025, GLOBAL TECHNOLOGIES LTD's primary operations are through Primecare Supply, LLC, a B2B pharmaceutical procurement company launched in May 2025, and GTLL Advisory Group, LLC, a strategic consulting platform formed in May 2025, expected to commence revenue in fiscal year 2026.

Why did GLOBAL TECHNOLOGIES LTD terminate the GOe3, LLC acquisition?

GLOBAL TECHNOLOGIES LTD terminated the GOe3, LLC acquisition because GOe3 had not met key operational and financial milestones required under the Share Exchange Agreement. The company wrote off its investment and associated goodwill as of June 30, 2025.

What happened to GLOBAL TECHNOLOGIES LTD's 10 Fold Services, LLC subsidiary?

10 Fold Services, LLC ceased procurement operations in June 2025 following changes in FDA regulations and the expiration of GLP-1 shortage allowances. Its intellectual property, including customer and supplier contacts, was transferred to Primecare Supply, LLC.

What is the market value of GLOBAL TECHNOLOGIES LTD's non-affiliate common stock?

The aggregate market value of GLOBAL TECHNOLOGIES LTD's voting common stock held by non-affiliates was approximately $2,937,688 on December 31, 2024.

How many shares of GLOBAL TECHNOLOGIES LTD's common stock are outstanding?

As of December 29, 2025, there were 14,688,440,097 shares of GLOBAL TECHNOLOGIES LTD's Class A common stock outstanding.

What are the key risks for investors in GLOBAL TECHNOLOGIES LTD?

Key risks for GLOBAL TECHNOLOGIES LTD investors include the inability to remediate material weaknesses in internal controls, failure to secure additional financing, difficulty attracting qualified personnel, and the inherent uncertainty of profitability given its history of losses.

Does GLOBAL TECHNOLOGIES LTD conduct research and development?

No, GLOBAL TECHNOLOGIES LTD reported $0 in research and development costs for both the fiscal years ended June 30, 2025, and June 30, 2024.

What is Primecare Supply, LLC's business model?

Primecare Supply, LLC operates as a business-to-business (B2B) procurement company, connecting licensed 503B pharmaceutical manufacturers with licensed medical clinics across the United States using its proprietary Sinq Ops software platform. It earns revenue on a per-transaction basis.

When does GLOBAL TECHNOLOGIES LTD expect GTLL Advisory Group, LLC to generate revenue?

Management expects GTLL Advisory Group, LLC to commence revenue-generating operations in fiscal year 2026, as it did not commence financial operations during fiscal year 2025.

Is GLOBAL TECHNOLOGIES LTD considered a shell company?

The filing indicates 'No' to the question of whether the registrant is a shell company, as defined in Rule 12b-2 of the Exchange Act.

Risk Factors

Industry Context

Global Technologies Ltd is navigating a strategic pivot within the health technology and advisory services sectors. The health tech landscape is characterized by rapid innovation, increasing regulatory scrutiny, and a growing demand for digital health solutions and efficient supply chains. The advisory services segment operates in a competitive market with numerous firms offering specialized consulting to SMEs, particularly within the growing wellness industry.

Regulatory Implications

The company's recent experience with FDA regulations impacting GLP-1 products underscores the critical need for ongoing compliance monitoring and adaptability. Future regulatory changes in pharmaceutical procurement, health data privacy (e.g., HIPAA), or advisory service standards could pose significant risks to GTLL's new ventures.

What Investors Should Do

  1. Monitor revenue generation and growth of Primecare Supply, LLC and GTLL Advisory Group, LLC closely, as these are now the primary drivers of future value.
  2. Assess the company's ability to manage regulatory risks, particularly in the pharmaceutical and health tech sectors, given the recent shutdown of 10 Fold Services.
  3. Evaluate the long-term impact of zero R&D spending on the company's innovation pipeline and competitive positioning.
  4. Consider the implications of the extremely high number of shares outstanding (14.69B) on potential per-share earnings growth and stock price appreciation.
  5. Investigate the reasons behind the GOe3 acquisition failure and assess if similar operational or due diligence weaknesses could affect future strategic initiatives.

Key Dates

Glossary

503B pharmaceuticals
Compounded drugs prepared by an outsourcing facility that is registered with the U.S. Food and Drug Administration (FDA). These facilities have specific quality control and manufacturing standards. (Central to the business model of Primecare Supply, LLC, indicating a focus on a regulated segment of the pharmaceutical market.)
GLP-1 products
Glucagon-like peptide-1 receptor agonists, a class of drugs often used for managing type 2 diabetes and weight loss. Regulatory changes around these products can significantly impact related businesses. (The reason cited for the cessation of 10 Fold Services, LLC, highlighting the impact of specific drug class regulations on business operations.)
Goodwill
An intangible asset that arises when a company acquires another company for a price greater than the fair value of its identifiable net assets. It represents the future economic benefits arising from assets acquired in a business combination that are not individually identified and recognized. (The write-off of goodwill associated with the terminated GOe3 acquisition indicates a financial loss and a failure to realize expected synergies or value from the deal.)
Non-affiliate market value
The market capitalization of a company's publicly traded shares held by investors who are not considered insiders or affiliates of the company. (Indicates the market's perception of the company's value based on publicly traded shares, excluding those held by management or major stakeholders.)
Class A common stock
A class of common stock that typically carries voting rights, often held by the general public. (Specifies the type of shares outstanding, with the large number indicating potential for dilution and impacting per-share financial metrics.)

Year-Over-Year Comparison

Detailed comparative financial metrics are not available from the provided text. However, the strategic pivot indicates a significant shift from previous operations, with the cessation of 10 Fold Services and the termination of the GOe3 acquisition representing substantial changes. The launch of Primecare Supply and GTLL Advisory Group signifies the creation of new revenue streams, while the reported $0 R&D spend for both years suggests a consistent lack of investment in innovation.

Filing Stats: 4,369 words · 17 min read · ~15 pages · Grade level 16.4 · Accepted 2025-12-30 10:24:47

Key Financial Figures

Filing Documents

controls and procedures;

controls and procedures; risk that we fail to meet the requirements of the agreements under which we acquired our business interests, including any cash payments to the business operations, which could result in the loss of our right to continue to operate or develop the specific businesses described in the agreements; risk that we will be unable to secure additional financing in the near future in order to commence and sustain our planned development and growth plans; risk that we cannot attract, retain and motivate qualified personnel, particularly employees, consultants and contractors for our operations; risks and uncertainties relating to the various industries and operations we are currently engaged in; results of initial feasibility, pre-feasibility and feasibility studies, and the possibility that future growth, development or expansion will not be consistent with our expectations; risks related to the inherent uncertainty of business operations including profit, cost of goods, production costs and cost estimates and the potential for unexpected costs and expenses; risks related to commodity price fluctuations; the uncertainty of profitability based upon our history of losses; risks related to failure to obtain adequate financing on a timely basis and on acceptable terms for our planned development projects; risks related to environmental regulation and liability; risks related to tax assessments; or other risks and uncertainties related to our prospects, properties and business strategy. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this report. Except as required by law, we do not undertake to update or revise any of the forward-looking statements to conform these statements to actual r

Business

Business 5 Item 1A.

Risk Factors

Risk Factors 10 Item 1B. Unresolved Staff Comments 26 Item 1C. Cybersecurity 26 Item 2.

Properties

Properties 26 Item 3.

Legal Proceedings

Legal Proceedings 26 Item 4. Mine Safety Disclosures 26 PART II Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 27 Item 6.

Selected Financial Data

Selected Financial Data 29 Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 29 Item 7A.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 32 Item 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data 33 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosures 62 Item 9A.

Controls and Procedures

Controls and Procedures 62 Item 9B. Other Information 63 PART III Item 10. Directors, Executive Officers and Corporate Governance 65 Item 11.

Executive Compensation

Executive Compensation 68 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 69 Item 13. Certain Relationships and Related Transactions, and Director Independence 72 Item 14. Principal Accounting Fees and Services 73 PART IV Item 15. Exhibits 74 Item 16. Form 10-K Summary 74

Signatures

Signatures 75 4 PART I Item 1. Business. Overview Global Technologies, Ltd ("Global Technologies") was incorporated under the laws of the State of Delaware on January 20, 1999 under the name of NEW IFT Corporation. On August 13, 1999, the Company filed an Amended and Restated Certificate of Incorporation with the Our principal executive office is located at 806 Green Valley Road, Suite 200, Greensboro, North Carolina 27408 and our telephone number is (973) 233-5151. Our website address is www.globaltechnologiesltd.info . The information provided on our website is not part of this Annual Report and is therefore not incorporated by reference unless such information is otherwise specifically referenced elsewhere in this Annual Report. Current Operations Global Technologies, Ltd is a multi-operational company with a strong desire to drive transformative innovation and sustainable growth across the technology and service sectors, empowering businesses and communities through advanced, scalable solutions that enhance connectivity, efficiency, and environmental stewardship. The Company envisions a future where technology seamlessly integrates into every aspect of life, improving the quality of life and the health of the planet. Our vision is to lead the industries we serve with groundbreaking initiatives that set new standards in innovation, customer experience, and corporate responsibility, thereby creating enduring value for all shareholders. Our wholly owned operating subsidiaries: About Primecare Supply, LLC Primecare Supply, LLC ("Primecare Supply") was formed as a Wyoming limited liability company on October 22, 2024, and commenced operations in May 2025. Primecare Supply operates as a business-to-business (B2B) procurement company powered by the proprietary Sinq Ops software platform. The Company's mission is to streamline and modernize the pharmaceutical supp

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing